Sunitinib as Second‐Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the <scp>SUN</scp> ‐ <scp>CK GERCOR</scp> Phase <scp>II</scp> Trial

20255 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov NCT01718327.

Good health and well-being

Published in: Liver International

Volume 45, Issue 8, pp. e70196-e70196

Field-Weighted Citation Impact: 10.14